NCT03226899 · Interventional trial
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
Overall registry status Terminated
Phase 4
Conditions Chronic Kidney Disease (CKD), Gout
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory